Clovis Oncology, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 13 rows in 2017. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-06-08: Reporting owner BLAIR JAMES C; Form 4; Security Stock Option (Right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-06-08: Reporting owner BARRETT M JAMES; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-06-08: Reporting owner SPICKSCHEN THORLEF; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-06-08: Reporting owner Flaherty Keith T.; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-06-08 | BLAIR JAMES C Director | 4 | Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $59.56 exercise price | 2017-06-12 | |
| 2017-06-08 | BARRETT M JAMES Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $59.56 exercise price | 2017-06-08 | |
| 2017-06-08 | SPICKSCHEN THORLEF Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $59.56 exercise price | 2017-06-08 | |
| 2017-06-08 | Flaherty Keith T. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $59.56 exercise price | 2017-06-08 | |
| 2017-06-08 | ATWOOD BRIAN G Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $59.56 exercise price | 2017-06-08 | |
| 2017-06-08 | GRAHAM GINGER L Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $59.56 exercise price | 2017-06-08 | |
| 2017-06-08 | KLINGENSTEIN PAUL H Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $59.56 exercise price | 2017-06-08 | |
| 2017-06-08 | McKinley Edward J Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $59.56 exercise price | 2017-06-08 | |
| 2017-03-27 | IVERS-READ GILLIAN C Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $68.31 exercise price | 2017-03-28 | |
| 2017-03-27 | MUEHL DANIEL W Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $68.31 exercise price | 2017-03-28 | |
| 2017-03-27 | MAHAFFY PATRICK J Director, Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $68.31 exercise price | 2017-03-28 | |
| 2017-03-27 | Hooks Corwin Dale Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $68.31 exercise price | 2017-03-28 | |
| 2017-03-27 | Rolfe Lindsey Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $68.31 exercise price | 2017-03-28 |